BREMETIDE™
Benefits
Increased Erections
Increased Sexual Arousal
Increased Satisfaction
History
In the 1980s, scientists at the University of Arizona began working on a peptide called Melanotan II (MT II) as a potential agent for sunless tanning. It worked. MT II induced darkening of skin pigment, but interestingly enough, it also caused increased sexual arousal and spontaneous erections in nine out of ten original male volunteers.
It was later shown that systemic administration of MT II caused penile erections in a variety of species, including humans.
BREMELANOTIDE
Development of BREMETIDE™
BREMETIDE™ (Bremelanotide) is an active derivative of MT II and has been shown to induce erections by activating the melanocortin receptors in the hypothalamus of the central nervous system.
BREMETIDE™ is clinically shown to be effective in treating sexual dysfunction in both men (erectile dysfunction) and women (sexual arousal disorder).
Unlike Viagra and other related medications, which act on the vascular system, BREMETIDE™ exerts its effects directly at the central nervous system, thus eliciting a natural sexual response with its usual feeling of sexual arousal and satisfaction.
Administration of BREMETIDE™ is well-tolerated and is not associated with hypotension often observed with other common drugs, such as Viagra or Cialis.
Benefits of BREMETIDE™
BREMETIDE™ has been shown to:
- Increase erections in 80% of men who do not respond to Viagra or Cialis.
- Increase sexually satisfying experiences in women by 50%.
- Increase sexual libido in both men and women.
Your physician may prescribe BREMETIDE™ as a stand-alone therapeutic agent or in combination with other treatments, such as ICP or Erexafil™.
How do I use it?
BREMETIDE™ is injected just below the skin in the lower abdomen.
It is prepared in 10 mg/ml, in a 2 ml vial. Men should start at 0.1 ml (10 units) and titrate up to 0.2 ml (20 units) if necessary; 2-6 hours prior to sexual activity. The initial dose will establish a time frame for response. The effects may last over 24 hours.
Women should start at 0.2 ml.
Do not use BREMETIDE™ more than 3 times a week.
What are the side-effects?
The side-effects of BREMETIDE™ are uncommon and may include flushing, nausea, and gastrointestinal upset. Some patients report increased skin pigmentation similar to tanning, especially when having extended exposure to sunlight. There are no known contraindications.
References:
“Discovery that a melanocortin regulates sexual functions in male and female humans”. Peptides. 26 (10):1687-9
Hadley ME. (October 2005). https://pubmed.ncbi.nlm.nih.gov/15996790/
“Melanocortin receptors, melanotropic peptides and penile erection”. Current Topics in Medicinal Chemistry. 7 (11): 1098-1106.
King SH, Mayorov AV, Balse-Srinivasan P, Hruby VJ, Vanderah TW, Wessells H. (2007) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694735/
“Melanocortins in the treatment of male and female sexual dysfunction”.
Shadiack, Annette & D Sharma, Shubh & C Earle, Dennis & Spana, Carl & J Hallam, Trevor. (2007). https://pubmed.ncbi.nlm.nih.gov/17584134/
This information is provided for general reading only. It is not intended to diagnose or treat any medical condition for any patient.
Please consult your treating physician for any concerns you may have.